专业监测看板

Pilot Study of Redirected Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic Leukemia

药物 / 成分：anti-CD19 redirected NK cells

登记的停止原因（原文）：Suspended for an interim review of (CAR) CD19 research strategy for the treatment of CD19 positive ALL.

Cefalium® Compared to Tylenol® in the Treatment of Migraine Attacks

药物 / 成分：Acetaminophen+Caffeine+Dihydroergotamine+Metoclopramide.、Acetaminophen

登记的停止原因（原文）：Strategic reasons of the company

Vitamin D and Bone Homeostasis in Ortho Polytrauma Patients

药物 / 成分：Ergocalciferol 8000 IU/ML Oral Liquid [DRISDOL]、Propylene Glycol

登记的停止原因（原文）：Waiting for annual IRB progress report to be reviewed and approved

Spinal Morphine for Patients With Obstructive Sleep Apnea

药物 / 成分：Intrathecal Morphine、No Intrathecal Morphine

登记的停止原因（原文）：competing studies

Lenvatinib Plus PD-1 Antibody for Unresectable ICC

药物 / 成分：Lenvatinib、PD-1 antibody

登记的停止原因（原文）：Protocol modification

Neural Response to Catecholamine Depletion in Subjects Suffering From Bulimia Nervosa in Their Past and Healthy Controls

药物 / 成分：AMPT/ Demser、Diphenhydramine、Placebo

登记的停止原因（原文）：Conduct of the first analyses

Preeclampsia: A Marker for Future Cardiovascular Risk in Women

药物 / 成分：Irbesartan

登记的停止原因（原文）：Pending funding

Angiotensin II for Septic Shock Treatment

药物 / 成分：Angiotensin II、Normal saline、Norepinephrine

登记的停止原因（原文）：The drug is not available

Phase III Study of Compound Formula Realgar-Indigo Naturalis Plus Imatinib Versus Placebo Plus Imatinib in Adult CML-CP Patients With Ph+

药物 / 成分：Compound realgar natural indigo Tablet、placebo

登记的停止原因（原文）：not enough patients

Safety and Efficacy of Oshadi D and Oshadi R for Malignant Mesothelioma Treatment

药物 / 成分：Oshadi D and Oshadi R

Oshadi D & Oshadi R Combined With Salvage Chemotherapy for Relapsed Acute Myeloid Leukemia or Lymphoid Leukemia Patients

药物 / 成分：Oshadi D & Oshadi R;、salvage therapy cytosar and mitoxantrone

Target Hemodynamics and Brain Injury During General Anesthesia in the Elderly

药物 / 成分：Hemodynamic target、Phenylephrine、Intravenous fluids、Patient's positioning

登记的停止原因（原文）：Pending Pilot study results evaluation

Impact on Morbidity and Mortality of Prophylactic Dosing of Low Molecular Heparin in Child-Pugh B Cirrhotic Patients

药物 / 成分：Enoxaparine

登记的停止原因（原文）：Premature discontinuation of inclusions by the sponsor for low inclusion

The Impact of RPh201 on Chronic Vegetative State (CVS): fMRI Study

药物 / 成分：RPh201、Saline

登记的停止原因（原文）：due to lack of supply of medication and technical problems with the MRI

Ulinastatin in Severe Acute Pancreatitis

药物 / 成分：ulinastatin、placebo

登记的停止原因（原文）：Revised project

Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis

药物 / 成分：Atorvastatin、Placebo

登记的停止原因（原文）：Enrollment target could not be achieved.

Effect of Cytokines on Growth of Children With Chronic Kidney Failure

药物 / 成分：Recombinant Human Growth Hormone

Feasibility of Polychromatic Light Emitting Diode System to Reduce Pain

药物 / 成分：UVL1000 Treatment Station、Normal Saline 0.9% Infusion Solution Bag、Peripheral Catheterization

登记的停止原因（原文）：Lack of Funding

Multiple Antigen Specific Cell Therapy (MASCT) for Hepatocellular Carcinoma(HCC) Patients After Radical Resection or Radio Frequency Ablation(RFA).

药物 / 成分：MASCT:Multiple Antigens Specific Cellular Therapy、The foundation treatment including against hepatitis b virus treatment using nucleoside analogue drug and protect liver treatment

登记的停止原因（原文）：Interim analysis

Effect of Intensive Therapy Associated With CSII on β-cell Function With Newly Diagnosed Type 2 Diabetes

药物 / 成分：CSII,ALA,MET,RSG